Spero Therapeutics, Inc.
Spero Therapeutics, Inc. received −$537K in federal prime contract obligations in the 12 months ending Oct 5, 2026, down 108.4% from $6.4M the year before, and $39.5M since FY2022. Its largest customer is the Department of Health and Human Services.
Contractor details
- Unique Entity ID (UEI)
- NX34PL7NZW24
- CAGE code
- 7SK81
- Headquarters
- Cambridge, MA
- Business size
- Small Business
As recorded on this UEI's most recent prime contract action in USAspending.gov. Confirm current registration and certifications in SAM.gov.
Obligations by fiscal year
Net prime contract obligations by federal fiscal year.
Top agencies
Funding agencies ranked by obligations since FY2022.
| Funding agency | Latest 12 mo | Since FY2022 |
|---|---|---|
| Department of Health and Human Services | −$537K | $39.5M |
Top NAICS codes
Industry codes agencies recorded on this contractor's awards, since FY2022.
What it sells
Product and service codes (PSC) on this contractor's awards, since FY2022.
| PSC | Description | Since FY2022 |
|---|---|---|
| AN13 | Health R&D services; Health Care services; Experimental Development | $31.1M |
| AN11 | Health R&D services; Health Care services; Basic Research | $8.4M |
Prime contracts (award types A–D) from USAspending.gov through Oct 5, 2026. Subcontracts are not included. Net obligations include deobligations and corrections.
Ready to connect your pursuit work?
GovEagle gives BD directors, capture managers, and proposal teams one AI workspace from pipeline through proposal, with CMMC/FedRAMP Certified compliance built in.